CHINA PHARMA HOLDINGS, INC. Deferred Tax Assets, Tax Credit Carryforwards
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Tax Assets, Tax Credit Carryforwards of $5.28 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards $5.28M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards $5.04M.
- 2021-12-31: Deferred Tax Assets, Tax Credit Carryforwards $5.78M.
- 2020-12-31: Deferred Tax Assets, Tax Credit Carryforwards $9.54M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2023-12-31 | $5.28M 10-K · filed 2024-04-01 |
| 2022-12-31 | $5.04M 10-K · filed 2024-04-01 |
| 2021-12-31 | $5.78M 10-K · filed 2023-03-30 |
| 2020-12-31 | $9.54M 10-K · filed 2022-03-30 |
| 2019-12-31 | $12.68M 10-K · filed 2021-03-26 |
| 2018-12-31 | $13.12M 10-K · filed 2020-03-30 |
| 2017-12-31 | $14.57M 10-K · filed 2019-03-28 |
| 2016-12-31 | $12.66M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |